Senior insider sale
Chief Scientific Officer at NEUROGENE INC. — senior position signals high conviction
$105.4K
6.80K shares
What this filing means
COBB STUART plans to sell 6.80K shares of NEUROGENE INC. valued at approximately $105.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/14/2025ACC: 0001950047-25-003006
Officer· Chief Scientific Officer
Since Feb 2026
6.80K
Shares to sell
$105.4K
Approx. market value
6.80K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
3/13/2025
6.80KTotal acquired6.80K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/13/2025 | Restricted Stock Units N/A | 6.80K | — |
| Total | 6.80K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
6.80K
Market value
$105.4K
5/14/2025
Total
Units
6.80K
Value
$105.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/14/2025 | 6.80K | $105.4K | NASDAQ | Planned |
| Total | 6.80K | $105.4K | ||